https://www.prnewswire.com/news-releases/emmecell-completes-last-patient-last-visit-for-proof-of-concept-trial-of-groundbreaking-cell-therapy-for-corneal-edema-302269420.html
Emmecell Completes Last Patient Last Visit for Proof-of-Concept Trial of Groundbreaking Cell...
/PRNewswire/ -- Emmetrope Ophthalmics, LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based...
proof of conceptlast patient